• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE PROA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE PROA EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1128350-28
Device Problems Deflation Problem (1149); Entrapment of Device (1212); Inflation Problem (1310); Material Separation (1562); Difficult to Advance (2920)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/10/2020
Event Type  Injury  
Manufacturer Narrative
The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.The xience proa device is currently not commercially available in the u.S.; however, it is similar to a device sold in the u.S.
 
Event Description
It was reported that the procedure was to treat a mildly tortuous, moderately calcified, proximal left anterior descending (plad) artery.A 3.50x28mm xience proa met resistance with the anatomy during advancement and it was noted that there was difficulty inflating and deflating due to the placement of the buddy wire, but ultimately the stent was implanted successfully.During the removal of the stent delivery system (sds), there was resistance due to anatomy and the guide wire.The sds separated at the proximal marker of the catheter.The separated portion was successfully retrieved by performing bypass surgery.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Event Description
It was reported that the procedure was to treat a mildly tortuous, moderately calcified, proximal left anterior descending (plad) artery.A 3.50x28mm xience proa met resistance with anatomy during advancement and it was noted that there was difficulty inflating and deflating due to the placement of the buddy wire, but ultimately the stent was implanted successfully.During the removal of the stent delivery system (sds), there was resistance due to anatomy and the guide wire.The sds separated at the proximal marker of the catheter.The separated portion was successfully retrieved by performing bypass surgery.Additional information received subsequent to filing the initial mdr: due to the surgery there was a delay as the patient was transferred to another hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PROA EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10094146
MDR Text Key192374426
Report Number2024168-2020-04541
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 07/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/04/2023
Device Catalogue Number1128350-28
Device Lot Number0021961
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/12/2020
Initial Date FDA Received05/27/2020
Supplement Dates Manufacturer Received07/06/2020
Supplement Dates FDA Received07/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
-
-